Combination of platelet-rich plasma with degradable bioactive borate glass for segmental bone defect repair

Acta Orthopaedica Belgica

Volumn 77, Issue 1, 2011, Pages 110-115

  Zhang, Ya Dong ^a   Wang, Gang ^a   Sun, Yan ^a   Zhang, Chang Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bioactive borate glass (BG); Bone defect; Platelet rich plasma (PRP); Scaffold

Indexed keywords

BIOMATERIAL; BORIC ACID; GLASS; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE PROSTHESIS; MALE; PHYSIOLOGY; RABBIT; THROMBOCYTE RICH PLASMA; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE SUBSTITUTES; BORATES; GLASS; MALE; OSTEOGENESIS; PLATELET-RICH PLASMA; RABBITS; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 79955793653     PISSN: 00016462     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of Iliac crest bone graft harvesting. Clin Orthop Relat Res 1996;329:300-309. (Pubitemid 26274684)
2. Banks RE, Forbes MA, Kinsey SE. Release of the angiogenic cytokine VEGF from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956-964. (Pubitemid 28101786)
3. Bonewald LF, Mundy GR. Role of transforming growth factor beta in bone remodeling. Clin Orthop Relat Res 1990;250:261-276. (Pubitemid 20033993)
4. Bostrom MP, Saleh KJ, Einhorn TA. Osteoinductive growth factors in preclinical fracture and long bone defects models. Orthop Clin North Am 1999;30:647-658. (Pubitemid 29471306)
5. Damien C, Parsons R. Bone graft and bone graft sub - stitutes: review of current technology and applications. J Appl Biomat 1991;2:187-208.
6. Geiger F, Bertram H, Berger I et al. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 2005;20:2028-2035. (Pubitemid 41532788)
7. Jia WT, Zhang X, Luo SH. Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis. Acta Biomaterialia 2010;6:812-819.
8. Kawase T, Okuda K, Wolff LF, Yoshie H. Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol 2003;74:858-864. (Pubitemid 36874119)
9. Kiuru J, Viinikka L, Myllyla G, Personen K, Perheentupa J. Cytoskeleton-dependent release of human platelet epidermal growth factor. Life Sci 1991;49:1997-2003.
10. Liu X, Xie ZP, Zhang CQ. Bioactive borate glass scaffolds: in vitro and in vivo evaluationfor use as a drug delivery system in the treatment of bone infection. J Mater Sci Mater Med 2010;21:575-582.
11. Liu X, Huang WH, Fu HL. Bioactive borosIlicate glass scaffolds: in vitro degradation and bioactivity behaviors. J Mater Sci: Mater Med 2009;20:1237-1243.
12. Maloney JP, Silliman C, Ambruso DR. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998;275:H1054-1061.
13. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofacial Surg 2004;62:489-496. (Pubitemid 38451232)
14. Plachokova AS, van den Dolder J, Stoelinga PJ, Jansen JA. The early effect of platelet-rich plasma on bone healing in combination with an osteoconductive material in rat cranial defects. Clin Oral Impl Res 2007;18:244-251.
15. Steenfos HH. Growth factors and wound healing. Scand J Plast Reconstr Surg Hand Surg 1994;28:95-105. (Pubitemid 24184204)
16. Weibrich G, Kleis WK, Kunz-Kostomanolakis M, Loos AH, Wagner W. Correlation of platelet concentration in platlet-rich plasma to the extraction method, age, sex, and platlet count of the donor. Int J Oral Maxillofac Implants 2001;16:693-699. (Pubitemid 33674670)
17. Wittbjer J, Palmer B, Thorngren KG. Osteogenetic properties of reimplanted decalcified and undecalcified autologous bone in the rabbit radius. Scand J Plast Reconstr Surg 1982;16:239-244. (Pubitemid 13124270)
18. Xie ZP, Liu X, Jia WT. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin. J Controlled Release 2009;139:118-126.
19. Yao AH, Wang DP, Huang WH. In vitro bioactive characteristics of borate-based glasses with controllable degradation behavior. J Am Ceram 2007;90:303-306.